Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-200,000
Closed -$3.05M 89
2023
Q1
$3.05M Buy
+200,000
New +$2.61M 1.26% 30

Other funds holding ETNB

Silverarc Capital Management's ETNB Position: Q3 2025 in Review

Silverarc Capital Management sold out of 89bio (ETNB) in Q3 2025, closing a stake of 2,037,087 shares — an estimated $20M sold.

Silverarc Capital Management first reported a position in ETNB in Q4 2020 and held it in 14 quarters. The position peaked at $20M in Q2 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Silverarc Capital Management reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Silverarc Capital Management sold 2,037,087 89bio shares in Q3 2025, an estimated $20M.
  • Silverarc Capital Management first reported a position in 89bio in Q4 2020 and held it in 14 quarters.
  • Silverarc Capital Management's 89bio position peaked at $20M in Q2 2025.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Silverarc Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.